TRAITEMENT DE SAIGNEMENTS GASTRO-INTESTINAUX CHEZ DES PATIENTS ATTEINTS D'UNE FORME GRAVE DE LA MALADIE DE VON WILLEBRAND PAR L'ADMINISTRATION DE VWF RECOMBINE
The present invention relates to a method for treating gastrointestinal bleeding in a subject with severe von Willebrand Disease comprising administering to the subject at least one dose of recombinant von Willebrand Factor (rVWF) ranging from about 40 IU/kg to about 100 IU/kg, wherein the first dose further comprises recombinant Factor VIII (rFVIII).